Delivery Order SPE2DB22D3501-SPE2DB25FXG31
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $4,467.35 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 6, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,377.81 to AmerisourceBergen Drug Corp on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price, competitively awarded delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The delivery order represents a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,090.80 to AmerisourceBergen Drug Corp on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. The vendor,...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $17,894.90 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is set to be completed by July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $77,463.67 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, effective through August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The award is non-set-aside and was competitively...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,672.43 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office division. The contract will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. As a child order under...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $52,252.74 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company will fulfill pharmaceutical and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $87,321.50 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $42,288.33 to AmerisourceBergen Drug Corp on August 27, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and runs through December 2026. The delivery order will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXG31Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,471.02 to AmerisourceBergen Drug Corp for the supply of Aponvie 32 mg/4.4 mL vials. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its established relationship with the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive experience fulfilling military and veteran healthcare pharmaceutical needs, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order represents a routine transaction under the company's existing prime vendor agreement structure, which allows the Defense Logistics Agency to efficiently procure pharmaceutical commodities to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/10/25 |